Methods and systems for disease treatment using electrical stimulation

• US 9,895,539 B1
• Filed: 06/09/2014
• Issued: 02/20/2018
• Est. Priority Date: 06/10/2013
• Status: Active Grant

• Current Assignee: Nevro Corporation
• Original Assignee: Nevro Corporation
• Inventors: Heit, Gary, Gliner, Bradford Evan
• Primary Examiner(s): Koharski, Christopher D
• Assistant Examiner(s): Carey, Michael
• Application Number:
  US14/300,193
• Time in Patent Office: 1,352 Days
• Field of Search: 607 46, 607 72, 607116, 607117
• CPC Class Codes: A61N 1/36062 Spinal stimulation
• CPC Class Codes: A61N 1/36071 Pain
• CPC Class Codes: A61N 1/36157 Current A61N1/3616 takes precedence
• CPC Class Codes: A61N 1/36171 Frequency
• CPC Class Codes: A61N 1/36175 Pulse width or duty cycle

Abstract

Systems for disease treatment using electrical stimulation are disclosed. A representative method for treating a patient includes changing an activity, expression, or both activity and expression of a fast sodium channel, a glial cell, or both a fast sodium channel and a glial cell of the patient by applying to a target neural population of the patient an electrical therapy signal having a frequency in a frequency range of 1.5 kHz to 100 kHz.

Claims

1. A method for treating a patient by changing an activity, expression, or both activity and expression of a fast sodium channel, a glial cell, or both a fast sodium channel and a glial cell of the patient, comprising:

using a signal generator to generate an electrical therapy signal having a frequency in a frequency range of 1.5 kHz to 100 kHz;

transmitting the electrical therapy signal to a signal delivery element positioned proximate to a target neural population located in the patient'"'"'s central nervous system;

applying the electrical therapy signal to the target neural population located in the patient'"'"'s central nervous system, wherein the electrical therapy signal

produces changes in the activity, expression, or both activity and expression of the fast sodium channel, the glial cell, or both the fast sodium channel and the glial cell of the patient.

2. The method of claim 1 wherein the changes reduce chronic pain in the patient.

3. The method of claim 1 wherein the changes include a change in a conductance of the fast sodium channel.

4. The method of claim 1 wherein the changes include a downregulation of the activity, expression, or both activity and expression of the fast sodium channel, the glial cell, or both the fast sodium channel and the glial cell of the patient.

5. The method of claim 1 wherein the changes includes an attenuation of pathology-induced sodium channel activity.

6. The method of claim 1 wherein the changes include a normalization of pathological neural networks associated with fast sodium channel activity, expression, or both.

7. The method of claim 1 wherein the changes include a modulation of glial neuronal cell interaction.

8. The method of claim 1 wherein the changes include a reduction of glial cell activity by reducing an extracellular potassium level.

9. The method of claim 1 wherein a frequency of the electrical therapy signal affects NaV1.8, NaV1.9, or both NaV1.8 and NaV1.9 sodium channels over another, slower sodium channel.

10. The method of claim 9, further comprising applying the therapy signal to increase an activity, expression, or both activity and expression of the slower sodium channel.

11. The method of claim 10 wherein the slower sodium channel includes a NaV1.3 channel.

12. The method of claim 1 wherein said changes include a decrease in a release, by glial cells, of at least one of nitric oxide, a proinflammatory cytokine, an excitatory amino acids, or a prostaglandin.

13. The method of claim 1 wherein the target neural population is at the patient'"'"'s spinal cord.

14. The method of claim 1 wherein the target neural population is at a peripheral nerve of the patient.

15. The method of claim 1 wherein the changes include an increase in the activity, expression, or both activity and expression of the fast sodium channel, the glial cell, or both the fast sodium channel and the glial cell of the patient.

16. The method of claim 1 wherein the changes include a decrease in the activity, expression, or both activity and expression of the fast sodium channel, the glial cell, or both the fast sodium channel and the glial cell of the patient.

17. The method of claim 1 wherein the electrical therapy signal has a pulse width in a pulse width range of 10 microseconds to 333 microseconds.

18. The method of claim 1 wherein the electrical therapy signal has an amplitude in an amplitude range of 0.1 mA to 20 mA.

19. The method of claim 1 wherein the electrical therapy signal has a duty cycle in a duty cycle range of 5% to 75%.

20. The method of claim 1 wherein the electrical signal has a pulse width in a pulse width range of 10 microseconds to 333 microseconds and an amplitude in an amplitude range of 0.1 mA to 20 mA.

21. A method for treating a patient by changing an activity, expression, or both activity and expression of a fast sodium channel, a glial cell, or both a fast sodium channel and a glial cell of the patient, comprising:

using a signal generator to generate an electrical therapy signal having a frequency in a frequency range of 1.5 kHz to 100 kHz, a pulse width in a pulse width range of 10 microseconds to 333 microseconds and an amplitude in an amplitude range of 0.1 mA to 20 mA;

transmitting the electrical therapy signal to a signal delivery element positioned proximate to a target neural population located in the patient'"'"'s central nervous system;

applying the electrical therapy signal to the target neural population located in the patient'"'"'s central nervous system, wherein the electrical therapy signal produces changes in the activity, expression, or both activity and expression of the fast sodium channel, the glial cell, or both the fast sodium channel and the glial cell of the patient, and wherein the electrical therapy signal treats chronic pain.

22. The method of claim 21 wherein the electrical therapy treats chronic back pain and wherein the target neural population is at a thoracic vertebral level.

23. A method for treating a patient by changing an activity, expression, or both activity and expression of a fast sodium channel, a glial cell, or both a fast sodium channel and a glial cell of the patient, comprising:

using a signal generator to generate an electrical therapy signal having a pulse width in a pulse width range of 10 microseconds to 333 microseconds;

transmitting the electrical therapy signal to a signal delivery element positioned proximate to a target neural population located in the patient'"'"'s central nervous system;

applying the electrical therapy signal to the target neural population located in the patient'"'"'s central nervous system, wherein the electrical therapy signal produces changes in the activity, expression, or both activity and expression of the fast sodium channel, the glial cell, or both the fast sodium channel and the glial cell of the patient.

24. The method of claim 23 wherein the changes produced by the electrical therapy signal reduce chronic pain in the patient.

25. The method of claim 23 wherein a frequency of the electrical therapy signal is in a range of 1.5 kHz to 100 kHz.

26. A method for treating a patient by changing an activity, expression, or both activity and expression of a fast sodium channel, a glial cell, or both a fast sodium channel and a glial cell of the patient, comprising:

using a signal generator to generate an electrical therapy signal having a frequency in a frequency range of 1.5 kHz to 100 kHz;

transmitting the electrical therapy signal to a signal delivery element positioned proximate to a target neural population located in the patient'"'"'s central nervous system; and

applying the electrical therapy signal to the target neural population,

wherein the electrical therapy signal produces changes in the activity, expression, or both activity and expression of the fast sodium channel, the glial cell, or both the fast sodium channel and the glial cell of the patient, and

wherein the target neural population is remote from the fast sodium channel, the glial cell, or both the fast sodium channel and the glial cell.